CVD is the most common cause of death worldwide(1)

  • 50% of untreated patients with onset symptoms of Aortic Stenosis die within 2 years2
  • 5 Million Americans are diagnosed with aortic valve stenosis each year2

Minimally invasive therapies for CVD are increasing

Portfolio of Solutions
dedicated to Interventional Cardiology

    Find the right IGS series for your cardiac interventions

    Optima™ 3 IGS Series*


    Versatility within your reach
    Optima™ IGS 320
    Optima™ IGS 330

    Innova™ IGS 5


    As flexible as it is powerful
    IGS 520
    IGS 530
    IGS 540

    Innova™ IGS 6


    Biplane image-guided system
    IGS 620
    IGS 630

    Discovery IGS™ 7


    Free yourself from the rails
    IGS 730
    IGS 740

    Discovery IGS™ 7 OR


    Rediscover space and movement
    IGS 730 OR
    IGS 740 OR

    Diagnostics & PCI

    Main challenges in Coronary Angiography

    Structural Heart

    Main challenges in Structural Heart
    1. Most common cause of death worldwide.
    2. According to the American Heart Association (AHA), more than 5 million Americans are diagnosed with aortic valve stenosis each year. An estimated 1.5 million people suffer from aortic stenosis in the United States with prevalence of 5% over 75 years of age. Patients with aortic stenosis have congested blood flow across the aortic
      valve in the heart and are at high surgical risk. Over 10 to 20 years, these patients experience noticeable symptoms, such as chest pain and heart failure, with mortality
      rates at 1 year and 2 years at approximately 25% and 50%, respectively. The Global Emerging Interventional Cardiac Devices Market Increasing Adoption of New
      Technologies in Emerging Markets Provides Impetus to Growth - Frost & Sullivan - ND01-54 - February 2014

    * IGS 3 series refer to Optima IGS 320 or Optima IGS 330